IHH Healthcare BhdXKLS:5225 +0.60%88 EBITDA Margin % is 26.16% as of Mar. 2026, which is 18% above its 10-year median of 22.25. GuruFocus rates XKLS:5225 with a GF Score™ of 88/100 and a GF Value™ of RM8.11 (Fairly Valued). The stock has 7 warning signs investors should review. Among 664 Healthcare Providers & Services companies, IHH Healthcare Bhd ranks better than 85.09% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. IHH Healthcare Bhd's EBITDA for the
three
months ended in Mar. 2026 was RM1,714 Mil. IHH Healthcare Bhd's Revenue for the
three
months ended in Mar. 2026 was RM6,553 Mil. Therefore, IHH Healthcare Bhd's EBITDA margin for the quarter that ended in Mar. 2026 was 26.16%.
IHH Healthcare Bhd (XKLS:5225) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
IHH Healthcare Bhd EBITDA Margin % Related Terms
IHH Healthcare Bhd EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for IHH Healthcare Bhd's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:5225 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, IHH Healthcare Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IHH Healthcare Bhd EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IHH Healthcare Bhd's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where IHH Healthcare Bhd's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IHH Healthcare Bhd (XKLS:5225) has a EBITDA Margin % of 26.16% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on IHH Healthcare Bhd and its competitors. This is 18% above median its historical median of 22.25. Over the past decade, IHH Healthcare Bhd's EBITDA Margin % has ranged from 17.15 to 29.85. According to the industry distribution chart, IHH Healthcare Bhd ranks #99 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 14.9%.
Is IHH Healthcare Bhd's EBITDA Margin % too high?
IHH Healthcare Bhd's current EBITDA Margin % of 26.16% is 18% above median its 10-year median of 22.25. Over the past 10 years, this metric has ranged from a low of 17.15 to a high of 29.85. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. IHH Healthcare Bhd's value of 26.16% is 156.2% above this industry median. Based on the distribution chart, IHH Healthcare Bhd ranks #99 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, IHH Healthcare Bhd has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IHH Healthcare Bhd's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, IHH Healthcare Bhd ranks #99 out of 664 companies for EBITDA Margin %. This places IHH Healthcare Bhd in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. IHH Healthcare Bhd's value of 26.16% is 156.2% above this benchmark. Historically, IHH Healthcare Bhd's own EBITDA Margin % has ranged from 17.15 to 29.85 over the past decade. While the company's 10-year median is 22.25 vs. the industry median of 10.21, IHH Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IHH Healthcare Bhd's current EBITDA Margin % of 26.16% is 156.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on IHH Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IHH Healthcare Bhd's current EBITDA Margin % is 26.16%, which is 18% above median its own 10-year median of 22.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IHH Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, IHH Healthcare Bhd (XKLS:5225) is currently considered Fairly Valued. The stock's GF Value™ is RM8.11, compared to a current price of RM8.38 — trading 3.3% above its estimated fair value. The current EBITDA Margin % is 26.16%, which is 18% above median its 10-year median of 22.25 and 156.2% above the Healthcare Providers & Services industry median of 10.21. IHH Healthcare Bhd's overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For IHH Healthcare Bhd (XKLS:5225), the current EBITDA Margin % is 26.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IHH Healthcare Bhd (XKLS:5225) Overvalued in 2026?
Based on GuruFocus' analysis, IHH Healthcare Bhd stock appears to be overvalued.
The current stock price of RM8.38 is trading 3.3% above its estimated GF Value™ of RM8.11.
GuruFocus considers IHH Healthcare Bhd to be Fairly Valued.
Key valuation signals for XKLS:5225:
EBITDA Margin %: 26.16% (18% above median its 10-year median of 22.25)
GF Value™: RM8.11 vs. price of RM8.38 (3.3% above fair value)
Industry Position: 156.2% above the Healthcare Providers & Services median (#99 of 664)
No single metric tells the full story. See the XKLS:5225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IHH Healthcare Bhd is an investment holding company. Through its subsidiaries, it is a healthcare services provider that operates a network of hospitals. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The company's reportable segments include Healthcare services, Laboratories services, and Management fees. The majority of its revenue is generated from the Healthcare services segment, which relates to contracts with patients in which performance obligations are to provide healthcare services. Geographically, the company derives maximum revenue from Turkiye and Europe, followed by Singapore, Malaysia, India, Greater China, and Others.
88GF Score
Get the complete analysis for XKLS:5225
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5225 has been successfully added to your 
